http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7201952-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79b5f9d76648dfc226a261cfb970de9c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-54
filingDate 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4172ee43bd9b704e36db8157a98e844a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5273bf00f065a161988e04ddc11f052
publicationDate 2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7201952-B2
titleOfInvention Low voltage e-paper
abstract A cholesteric display including a liquid crystalline mixture having a dipolar dopant dissolved in the liquid crystalline mixture and the resulting mixture is reflecting light in the visible range of the spectrum when in planar state. In accordance with another aspect, a process includes forming a composition with a dipolar molecule to result in a liquid crystal dipolar dopant, and liquid crystal is added to the composition. In accordance with still another aspect, a device includes a liquid crystal composition includes a cholesteric liquid and a dipolar dopant. The liquid crystal composition is switchable between a focal-conic state and a planar state in the presence of an electric field and is stable in the respective state when the electric field is removed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9301569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8474146-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10021933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3549472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8769836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011163125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8650764-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4256999-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3827687-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9226542-B2
priorityDate 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3697150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6767480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004115366-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6824708-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID143205176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226519041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128111001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20743162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128099497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129885509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239434727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425185209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227058903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71201489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248245346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239527442

Total number of triples: 48.